Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML
Authors:
- Xiaonan WangXiaonan Wang
- Alison KennedyAKAlison Kennedy
- Konstantinos TzelepisKTKonstantinos Tzelepis
- George GiotopoulosGGGeorge Giotopoulos
- Pedro M. QuirosPQPedro M. Quiros
- Kim WongKWKim Wong
- David J. AdamsDADavid J. Adams
- Larissa S. CarnevalliLCLarissa S. Carnevalli
- Brian J. P. HuntlyBHBrian J. P. Huntly
- George S. VassiliouGVGeorge S. Vassiliou
Open Access
- 16 March 2020
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-15
Abstract
Leukaemogenic mutations commonly disrupt cellular differentiation and/or enhance proliferation, thus perturbing the regulatory programs that control self-renewal and differentiation of stem and progenitor cells. Translocations involving theMll1(Kmt2a) gene generate powerful oncogenic fusion proteins, predominantly affecting infant and paediatric AML and ALL patients. The early stages of leukaemogenic transformation are typically inaccessible from human patients and conventional mouse models. Here, we take advantage of cells conditionally blocked at the multipotent haematopoietic progenitor stage to develop a MLL-r model capturing early cellular and molecular consequences of MLL-ENL expression based on a clear clonal relationship between parental and leukaemic cells. Through a combination of scRNA-seq, ATAC-seq and genome-scale CRISPR-Cas9 screening, we identify pathways and genes likely to drive the early phases of leukaemogenesis. Finally, we demonstrate the broad utility of using matched parental and transformed cells for small molecule inhibitor studies by validating both previously known and other potential therapeutic targets.Keywords
This publication has 69 references indexed in Scilit:
- Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cellsCancer & Metabolism, 2013
- Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell ProliferationScience, 2012
- Mechanisms of Action of a Dual Cdc7/Cdk9 Kinase Inhibitor against Quiescent and Proliferating CLL CellsMolecular Cancer Therapeutics, 2011
- MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genomeBlood, 2011
- Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndromeOncogene, 2009
- F-Seq: a feature density estimator for high-throughput sequence tagsBioinformatics, 2008
- Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulinJournal of Clinical Investigation, 2008
- Malignant Transformation Initiated by Mll-AF9: Gene Dosage and Critical Target CellsCancer Cell, 2008
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006
- Continuous MLL-ENL Expression Is Necessary to Establish a “Hox Code” and Maintain Immortalization of Hematopoietic Progenitor CellsCancer Research, 2005